<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Toxicol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Toxicol. Sci</journal-id>
<journal-id journal-id-type="publisher-id">toxsci</journal-id>
<journal-title-group>
<journal-title>Toxicological Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">1096-6080</issn>
<issn pub-type="epub">1096-0929</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31173147</article-id>
<article-id pub-id-type="pmc">6736394</article-id>
<article-id pub-id-type="doi">10.1093/toxsci/kfz136</article-id>
<article-id pub-id-type="publisher-id">kfz136</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neurotoxicology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Using a Multi-Stage hESC Model to Characterize BDE-47 Toxicity During Neurogenesis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="kfz136-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Seifikar</surname>
<given-names>Helia</given-names>
</name>
<xref ref-type="aff" rid="kfz136-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Larocque</surname>
<given-names>Nicholas</given-names>
</name>
<xref ref-type="aff" rid="kfz136-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Yvonne</given-names>
</name>
<xref ref-type="aff" rid="kfz136-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khatib</surname>
<given-names>Ibrahim</given-names>
</name>
<xref ref-type="aff" rid="kfz136-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fernandez</surname>
<given-names>Charles J</given-names>
</name>
<xref ref-type="aff" rid="kfz136-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abello</surname>
<given-names>Nicomedes</given-names>
</name>
<xref ref-type="aff" rid="kfz136-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-2421-4535</contrib-id>
<name>
<surname>Robinson</surname>
<given-names>Joshua F</given-names>
</name>
<xref ref-type="corresp" rid="kfz136-cor1"></xref>
<!--<email>Joshua.Robinson@ucsf.edu</email>-->
<xref ref-type="aff" rid="kfz136-aff1"></xref>
</contrib>
</contrib-group>
<aff id="kfz136-aff1">Department of Obstetrics, Gynecology, and Reproductive Sciences, Center for Reproductive Sciences, University of California, San Francisco (UCSF), San Francisco, California 94143-0665</aff>
<author-notes>
<corresp id="kfz136-cor1">To whom correspondence should be addressed at Department of Obstetrics, Gynecology, and Reproductive Sciences, Center for Reproductive Sciences, University of California, San Francisco (UCSF), 513 Parnassus Avenue, Room 1621, San Francisco, CA 94143-0665. Fax: (415) 476-1635. E-mail: <email>Joshua.Robinson@ucsf.edu</email>.</corresp>
</author-notes>
<pub-date iso-8601-date="2019-06-07" pub-type="epub">
<day>07</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>171</volume>
<issue>1</issue>
<fpage>221</fpage>
<lpage>234</lpage>
<permissions>
<copyright-statement>Â© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="kfz136.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Although the ramifications associated with polybrominated diphenyl ethers (PBDEs) exposures during human pregnancy have yet to be determined, increasing evidence in humans and animal models suggests that these compounds cause neurodevelopmental toxicity. Human embryonic stem cells (hESCs) models can be used to study the effects of environmental chemicals throughout the successive stages of neuronal development. Here, using a hESC differentiation model, we investigated the effects of common PBDE congeners (BDE-47 or -99) on the successive stages of early neuronal development. First, we determined the points of vulnerability to PBDEs across 4 stages of <italic>in vitro</italic> neural development by using assays to assess for cytotoxicity. Differentiated neural progenitors were identified to be more sensitive to PBDEs than their less differentiated counterparts. In follow-up investigations, we observed BDE-47 to inhibit functional processes critical for neurogenesis (eg, proliferation, expansion) in hESC-derived neural precursor cells (NPCs) at sub-lethal concentrations. Finally, to determine the mechanism(s) underlying PBDE-toxicity, we conducted global transcriptomic and methylomic analyses of BDE-47. We identified 589 genes to be differentially expressed due to BDE-47 exposure, including molecules involved in oxidative stress mediation, cell cycle, hormone signaling, steroid metabolism, and neurodevelopmental pathways. In parallel analyses, we identified a broad significant increase in CpG methylation. In summary our results suggest, on a cellular level, PBDEs induce human neurodevelopmental toxicity in a concentration-dependent manner and sensitivity to these compounds is dependent on the developmental stage of exposure. Proposed mRNA and methylomic perturbations may underlie toxicity in early embryonic neuronal populations.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>polybrominated diphenyl ethers</kwd>
<kwd>human</kwd>
<kwd>embryonic stem cells</kwd>
<kwd>neurogenesis</kwd>
<kwd>neurotoxicity</kwd>
<kwd>transcriptome</kwd>
<kwd>methylome</kwd>
<kwd>alternative model</kwd>
<kwd>
<italic>in vitro</italic>
</kwd>
<kwd>endocrine disruptors</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Child Health and Human Development</named-content>
<named-content content-type="funder-identifier">10.13039/100000071</named-content>
</funding-source>
<award-id>T32HD007263</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">United States Environmental Protection Agency</named-content>
<named-content content-type="funder-identifier">10.13039/100000139</named-content>
</funding-source>
<award-id>RD883467801</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Institute of Environmental Health Sciences</named-content>
<named-content content-type="funder-identifier">10.13039/100000066</named-content>
</funding-source>
<award-id>K99ES023846</award-id>
<award-id>R00ES023846</award-id>
<award-id>P01ES022841</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="14"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>